Oxidative stress and vascular damage in hypertension: Role of angiotensin ii

International Journal of Hypertension

Volumn 2011, Issue , 2011, Pages

  Virdis, Agostino ^a   Duranti, Emiliano ^a   Taddei, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ALLOPURINOL; ANGIOTENSIN II; APOCYNIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LOSARTAN; PROSTAGLANDIN SYNTHASE; PROSTANOID RECEPTOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TETRAHYDROBIOPTERIN; XANTHINE OXIDASE;

BLOOD VESSEL WALL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; VASCULAR DISEASE; VASCULARIZATION;

EID: 82255171911     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2011/916310     Document Type: Review

References (49)

1. Schiffrin E. L., Reactivity of small blood vessels in hypertension: relation with structural changes: state of the art lecture. Hypertension 1992 19 2 II1 II9 2-s2.0-0026600669
2. Mulvany M. J., Baumbach G. L., Aalkjaer C., Vascular remodeling. Hypertension 1996 28 505 506 (Pubitemid 26298571)
3. Intengan H. D., Schiffrin E. L., Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000 36 3 312 318 2-s2.0-0033822718
4. Neves M. F., Virdis A., Schiffrin E. L., Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism. Journal of Hypertension 2003 21 1 189 198 2-s2.0-0037251361 10.1097/00004872- 200301000-00029 (Pubitemid 36143524)
5. Neves M. F., Endemann D., Amiri F., Virdis A., Pu Q., Rozen R., Schiffrin E. L., Small artery mechanics in hyperhomocysteinemic mice: effects of angiotensin II. Journal of Hypertension 2004 22 5 959 966 2-s2.0-2542496224 10.1097/00004872-200405000-00018 (Pubitemid 38680471)
6. Touyz R. M., Schiffrin E. L., Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacological Reviews 2000 52 4 639 672 2-s2.0-0033635110
7. Virdis A., Neves M. F., Amiri F., Viel E., Touyz R. M., Schiffrin E. L., Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002 40 4 504 510 2-s2.0-0036791717 10.1161/01.HYP. 0000034738.79310.06
8. Virdis A., Colucci R., Fornai M., Duranti E., Giannarelli C., Bernardini N., Segnani C., Ippolito C., Antonioli L., Blandizzi C., Taddei S., Salvetti A., Del Tacca M., Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 2007 49 3 679 686 2-s2.0-33847046810 10.1161/01.HYP.0000253085.56217.11
9. Schiffrin E. L., Park J. B., Intengan H. D., Touyz R. M., Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000 101 14 1653 1659 2-s2.0-0034636121 (Pubitemid 30196624)
10. Rajagopalan S., Kurz S., Münzel T., Tarpey M., Freeman B. A., Griendling K. K., Harrison D. G., Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. Journal of Clinical Investigation 1996 97 8 1916 1923 2-s2.0-0030005713
11. Warnholtz A., Nickenig G., Schulz E., Macharzina R., Bräsen J. H., Skatchkov M., Heitzer T., Stasch J. P., Griendling K. K., Harrison D. G., Böhm M., Meinertz T., Münzel T., Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999 99 15 2027 2033 2-s2.0-0033586639 (Pubitemid 29183901)
12. Griendling K. K., Sorescu D., Lassègue B., Ushio-Fukai M., Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 10 2175 2183 2-s2.0-0033781454
13. Landmesser U., Harrison D. G., Oxidative stress and vascular damage in hypertension. Coronary Artery Disease 2001 12 6 455 461 2-s2.0-0034764030 10.1097/00019501-200109000-00004 (Pubitemid 32977815)
14. Touyz R. M., Schiffrin E. L., Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999 34 4 976 982 2-s2.0-0032737361 (Pubitemid 29501333)
15. Touyz R. M., Tabet F., Schiffrin E. L., Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clinical and Experimental Pharmacology and Physiology 2003 30 11 860 866 2-s2.0-0344304669 10.1046/j.1440-1681.2003.03930.x (Pubitemid 37506154)
16. Touyz R. M., Schiffrin E. L., Reactive oxygen species in vascular biology: implications in hypertension. Histochemistry and Cell Biology 2004 122 4 339 352 2-s2.0-8644277006 10.1007/s00418-004-0696-7 (Pubitemid 39506592)
17. Paravicini T. M., Touyz R. M., Redox signaling in hypertension. Cardiovascular Research 2006 71 2 247 258 2-s2.0-33745193908 10.1016/j.cardiores.2006.05.001
18. Suzuki H., Delano F. A., Parks D. A., Jamshidi N., Granger D. N., Ish H. II, Suematsu M., Zweifach B. W., Schmid-Schönbein G. W., Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proceedings of the National Academy of Sciences of the United States of America 1998 95 8 4754 4759 2-s2.0-0032516037 10.1073/pnas.95.8.4754 (Pubitemid 28207986)
19. Laakso J., Mervaala E., Himberg J. J., Teräväinen T. L., Karppanen H., Vapaatalo H., Lapatto R., Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension. Hypertension 1998 32 5 902 906 2-s2.0-0031740025 (Pubitemid 28530226)
20. Laakso J. T., Teräväinen T. L., Martelin E., Vaskonen T., Lapatto R., Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats. Journal of Hypertension 2004 22 7 1333 1340 2-s2.0-3042788745 10.1097/01.hjh.0000125441.28861.9f (Pubitemid 38888079)
21. Bagi Z., Koller A., Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin. Journal of Vascular Research 2003 40 1 47 57 2-s2.0-0037228474 10.1159/000068938 (Pubitemid 36351195)
22. Virdis A., Iglarz M., Neves M. F., Amiri F., Touyz R. M., Rozen R., Schiffrin E. L., Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 8 1352 1357 2-s2.0-0043235659 10.1161/01.ATV.0000083297.47245.DA (Pubitemid 36994521)
23. Landmesser U., Dikalov S., Price S. R., McCann L., Fukai T., Holland S. M., Mitch W. E., Harrison D. G., Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. Journal of Clinical Investigation 2003 111 8 1201 1209 2-s2.0-0037399439 10.1172/JCI200314172 (Pubitemid 36519937)
24. Guzik T. J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., Channon K. M., Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002 105 14 1656 1662 2-s2.0-0037046214 10.1161/01.CIR.0000012748.58444.08 (Pubitemid 34298608)
25. Higashi Y., Sasaki S., Nakagawa K., Fukuda Y., Matsuura H., Oshima T., Chayama K., Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. American Journal of Hypertension 2002 15 4 326 332 2-s2.0-0036100972 10.1016/S0895- 7061(01)02317-2 (Pubitemid 34408972)
26. Griendling K. K., Minieri C. A., Ollerenshaw J. D., Alexander R. W., Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circulation Research 1994 74 6 1141 1148 2-s2.0-0028365310 (Pubitemid 24176909)
27. Nickenig G., Strehlow K., Bäumer A. T., Baudler S., Wamann S., Sauer H., Böhm M., Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression. British Journal of Pharmacology 2000 131 4 795 803 2-s2.0-0035223411
28. Fukui T., Ishizaka N., Rajagopalan S., Laursen J. B., Capers Q., Taylor W. R., Harrison D. G., De Leon H., Wilcox J. N., Griendling K. K., p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circulation Research 1997 80 1 45 51 2-s2.0-0031015288 (Pubitemid 27030367)
29. Rey F. E., Cifuentes M. E., Kiarash A., Quinn M. T., Pagano P. J., Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circulation Research 2001 89 5 408 414 2-s2.0-0035980160 (Pubitemid 34132656)
30. Virdis A., Neves M. F., Amiri F., Touyz R. M., Schiffrin E. L., Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. Journal of Hypertension 2004 22 3 535 542 2-s2.0-1642276271 10.1097/00004872-200403000- 00016 (Pubitemid 38368487)
31. Jung O., Schreiber J. G., Geiger H., Pedrazzini T., Busse R., Brandes R. P., gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 2004 109 14 1795 1801 2-s2.0-3342983728 10.1161/01.CIR.0000124223.00113.A4 (Pubitemid 38500684)
32. Zhou M. S., Adam A. G., Jaimes E. A., Raij L., In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension 2003 42 5 945 951 2-s2.0-0242441471 10.1161/01.HYP.0000094220.06020.C8 (Pubitemid 37413735)
33. Zhou M. S., Schulman I. H., Pagano P. J., Jaimes E. A., Raij L., Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 2006 47 1 81 86 2-s2.0-31744449213 10.1161/01.HYP.0000197182.65554.c7 (Pubitemid 43177819)
34. 2 Hypertension 2005 46 4 732 737 2-s2.0-31944436458 10.1161/01.HYP.0000182660.74266.6d (Pubitemid 43186746)
35. Li L., Fink G. D., Watts S. W., Northcott C. A., Galligan J. J., Pagano P. J., Chen A. F., Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 2003 107 7 1053 1058 2-s2.0-0037465438 10.1161/01.CIR.0000051459.74466.46 (Pubitemid 36258731)
36. Elmarakby A. A., Loomis E. D., Pollock J. S., Pollock D. M., NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 2005 45 2 283 287 2-s2.0-13144293998 10.1161/01.HYP.0000153051.56460.6a (Pubitemid 40179973)
37. Amiri F., Virdis A., Neves M. F., Iglarz M., Seidah N. G., Touyz R. M., Reudelhuber T. L., Schiffrin E. L., Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 2004 110 15 2233 2240 2-s2.0-5644247979 10.1161/01.CIR.0000144462. 08345.B9 (Pubitemid 39372507)
38. Warner T. D., Mitchell J. A., Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. The FASEB Journal 2004 18 7 790 804 2-s2.0-2142695733 10.1096/fj.03-0645rev (Pubitemid 38544498)
39. Cipollone F., Rocca B., Patrono C., Cyclooxygenase-2 expression and inhibition in atherothrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 2 246 255 2-s2.0-1042268032 10.1161/01.ATV.0000104005.92603.f2 (Pubitemid 38197575)
40. Funk C. D., Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001 294 5548 1871 1875 2-s2.0-0035976575 10.1126/science.294. 5548.1871 (Pubitemid 33101574)
41. Yang D., Félétou M., Levens N., Zhang J. N., Vanhoutte P. M., A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR. Hypertension 2003 41 1 143 148 2-s2.0-0037219457 10.1161/01.HYP.0000047651.45322.16 (Pubitemid 36056806)
42. Ohnaka K., Numaguchi K., Yamakawa T., Inagami T., Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension 2000 35 1 68 75 2-s2.0-0033956858 (Pubitemid 30054239)
43. Young W., Mahboubi K., Haider A., Li I., Ferreri N. R., Cyclooxygenase-2 is required for tumor necrosis factor- α-and angiotensin II-mediated proliferation of vascular smooth muscle cells. Circulation Research 2000 86 8 906 914 2-s2.0-0034724903 (Pubitemid 30246989)
44. Hu Z. W., Kerb R., Shi X. Y., Wei-Lavery T., Hoffman B. B., Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. Journal of Pharmacology and Experimental Therapeutics 2002 303 2 563 573 2-s2.0-0036827946 10.1124/jpet.102.037705 (Pubitemid 35231227)
45. Rocha R., Martin-Berger C. L., Yang P., Scherrer R., Delyani J., McMahon E., Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 2002 143 12 4828 4836 2-s2.0-0036893647 10.1210/en.2002-220120 (Pubitemid 35397623)
46. Bohm H., Lee M., Kreutz R., Kim S., Schinke M., Djavidani B., Wagner J., Kaling M., Wienen W., Bader M., Ganten D., Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions. Journal of Hypertension 1995 13 8 891 899 2-s2.0-0029084629 10.1097/00004872-199508000-00010
47. Brassard P., Amiri F., Schiffrin E. L., Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries. Hypertension 2005 46 3 598 606 2-s2.0-25444459936 10.1161/01.HYP.0000176744.15592.7d (Pubitemid 41376842)
48. Cayatte A. J., Du Y., Oliver-Krasinski J., Lavielle G., Verbeuren T. J., Cohen R. A., The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 7 1724 1728 2-s2.0-0033925020 (Pubitemid 30470586)
49. Virdis A., 63rd Annual High Blood Pressure Research Conference. Hypertension 2009 54 e117. abstract no. P435